367P - Persistent elevation of plasma interleukin-8 or interferon-γ after curative chemoradiotherapy predict early tumor recurrence and poor survival outc...

Date 17 December 2016
Event ESMO Asia 2016 Congress
Session Poster lunch
Topics Anti-Cancer Agents & Biologic Therapy
Head and Neck Cancers
Translational Research
Presenter Yu-Li Lin
Citation Annals of Oncology (2016) 27 (suppl_9): ix112-ix122. 10.1093/annonc/mdw587
Authors Y. Lin1, J.L. Chen2, Y. Huang3
  • 1Medical Research, National Taiwan University Hospital, 100 - Taipei/TW
  • 2Oncology, National Taiwan University Hospital, 100 - Taipei/TW
  • 3Medical Imaging, National Taiwan University Hospital, 100 - Taipei/TW

Abstract

Background

To evaluate the prognostic significance of plasma proinflammatory cytokines in patients with head and neck squamous cell carcinoma undergoing curative chemoradiotherapy.

Methods

This prospective study was approved by the IRB of our institute (201406075RINC). Head and neck squamous cell carcinoma non-metastatic patients receiving curative chemoradiotherapy were prospectively enrolled. Proinflammatory plasma cytokines concentrations [interleukin (IL)-1β, IL-2, IL-4, IL-6, IL-8, IL-10, IFN-γ, and tumor necrosis factor-α] were evaluated at two time points (before chemoradiotherapy, and 2 weeks after completion of chemoradiotherapy). Associations of the plasma level of cytokines and clinical outcomes were evaluated.

Results

Thirty patients were included. The primary sites of cancer were oropharynx (33%), oral cavity (23%), hypopharynx (23%), larynx (10%), and others (10%). Most patients had stage IV disease. The median radiotherapy dose was 70 Gy in 33 fractions. With a median relative short follow-up of 15.9 months, early tumor recurrence was noted in twelve 12 patients (40%), and death was noted in 6 patients (20%). Among the 8 proinflammatory plasma cytokines, IL-8 and IFN-γ were significantly associated with survival outcomes. The mean IL-8 levels before and after treatment were 1.6 and 4.1 pg/mL, respectively. The mean IFN-γ level before and after treatment were 4.7 and 2.8 pg/mL, respectively. In univariate analysis, stage IV (p = 0.047), persistent elevation (level after treatment was greater than or equal to the level before treatment) of plasma IL-8 (p = 0.024) or IFN-γ (p = 0.006) were significantly associated with early tumor recurrence and poor overall survival. In multivariate analysis, patients with persistent elevation of plasma IL-8 or IFN-γ, independent of stage, had significantly worse RFS (HR 3.0, p = 0.038 for persistent elevation of plasma IL-8; HR 8.8, p = 0.026 for IFN-γ).

Conclusions

In patients with head and neck squamous cell carcinoma undergoing curative chemoradiotherapy, persistent elevation of plasma IL-8 or interferon-γ after treatment may predict early tumor recurrence and poor overall survival.

Clinical trial indentification

Legal entity responsible for the study

National Taiwan University Hospital

Funding

National Taiwan University Hospital

Disclosure

All authors have declared no conflicts of interest.